Genomines | $45,000,000 | (Sep 18, 2025)
Synthesize Bio | $10,000,000 | (Sep 18, 2025)
Moby | $5,000,000 | (Sep 18, 2025)
Certified by Founder
Lodge
Nephron Pharmaceuticals
start up
United States
- West Columbia, South Carolina
- 18/09/2023
- Unknown
- $350,000,000
Nephron Pharmaceuticals Corporation is a mid-sized company that manufactures generic respiratory medications. NPC sells to many classes of trade, including, but not limited to, hospitals, pharmacies, long term care facilities, home care companies and mail order pharmacies. These medications are used in the treatment of asthma and COPD.
- Industry Pharmaceutical Manufacturing
- Website https://www.nephronpharm.com/
- LinkedIn https://www.linkedin.com/company/nephron-pharm/about/
Invisible Technologies | $100,000,000 | (Sep 18, 2025)
Mueon Corporation | $15,500,000 | (Sep 18, 2025)
Stablecore | $20,000,000 | (Sep 18, 2025)
Envive AI | $15,000,000 | (Sep 18, 2025)
Markup AI | $27,500,000 | (Sep 18, 2025)
Turnout | $21,000,000 | (Sep 18, 2025)
GridStrong | $10,000,000 | (Sep 18, 2025)
Imagine Pediatrics | $67,000,000 | (Sep 18, 2025)
Rec Technologies | $11,000,000 | (Sep 18, 2025)